Senior Medical Director, Treatment - Global Medical Affairs, ViiV

Please note that this is a ‘internal job posting’ link, intended for GSK/ViiV employees only. Contingent Workers should check with the recruiter of the Job Requisition to confirm whether the job is open to contingent workers and to obtain the correct job posting hyperlink.

Please note it is your responsibility to notify your manager if you are interested in applying to an open position prior to the interview taking place. Please refer to your local policy for more information and guidelines.

Senior Medical Director, Treatment, ViiV

Purpose

Provide senior global medical leadership for the long-acting HIV portfolio, with primary accountability for an emerging treatment programme and its evidence, communication and launch-readiness agenda. Establish the global medical and scientific strategic direction, short- and long-term goals, and the overall planning and delivery of integrated medical affairs plans for the next-generation long-acting treatment portfolio.

Work in close partnership with the broader long-acting franchise to ensure a coherent, joined-up medical strategy across the portfolio. Collaborate across current and future long-acting and combination assets to maximise the collective value of the franchise and support a seamless scientific narrative across treatment and prevention. Build and develop a global medical capability to support the evolving portfolio, with responsibility for leading and developing a team of up to four professionals over time. Operate effectively within a complex, highly matrixed environment, navigating uncertainty and shaping strategy as the scientific, competitive and policy landscapes evolve.

Ensure ViiV Healthcare’s scientific and medical data are leveraged effectively and communicated in a fair, balanced and compliant manner in line with ABPI/PMCPA and other applicable codes. Partner across Clinical, Statistics, Regulatory, Safety, Commercial, Market Access, Policy, Scientific Communications and Compliance to shape the pipeline evidence strategy and support responsible commercialisation.

Accountabilities

Global medical accountability for an emerging pipeline treatment programme.

Partnership with the established long-acting treatment organisation to ensure alignment of strategy, evidence generation, scientific communications and lifecycle planning across the portfolio.

Cross-franchise influence across current and future long-acting / combination assets.

Decision rights over pipeline medical strategy, evidence prioritisation and scientific positioning, in partnership with the Global Medical Lead.

Influence over launch-readiness, resistance/pharmacology strategy and cross-functional evidence governance.

Responsibilities

Set and own the integrated global medical strategy and integrated evidence plan for the emerging pipeline treatment, spanning pre-launch to post-launch phases. Work in partnership with the established long-acting treatment team to create an aligned medical strategy, integrated evidence plan and coherent scientific narrative across the treatment portfolio.

Build, develop and lead a high-performing global medical capability to support the long-acting treatment pipeline, with responsibility for up to four direct reports as the organisation and portfolio evolve. Demonstrate strong collaborative leadership, build alignment across functions, and deliver effectively amid ambiguity, changing priorities and emerging evidence.

Work directly with other long-acting franchise leads to ensure a joined-up franchise medical strategy and consistent external scientific positioning.

Shape and oversee the pipeline evidence agenda, including Phase IIIb/IV studies, investigator-sponsored research, resistance and pharmacology strategy, and real-world and service-delivery evidence, in partnership with Clinical, Statistics and R&D.

Build and maintain effective relationships with external experts, HCPs, guideline bodies and communities, providing senior scientific expertise and facilitating medical scientific team engagement on long-acting treatment.

Ensure the scientific quality and compliance of all medical and promotional activities for the pipeline, acting as senior medical reviewer/signatory where appropriate, and proactively identifying and mitigating ABPI/PMCPA risk.

Partner with Scientific Communications to define and deliver the scientific platform, narrative and communication plan for long-acting treatment, ensuring consistency across regions.

Provide senior medical input to launch readiness, market access and commercial planning for pipeline assets, translating clinical differentiation into credible, evidence-based value messages.

Represent ViiV in senior internal governance and external scientific forums, advising leadership on the medical implications of the evolving long-acting treatment landscape and competitive environment.

  Basic Qualifications MD, PharmD or PhD in a medical / scientific discipline or public health Experience of working in the HIV or infectious disease therapy area

Proven experience leading global medical strategy and integrated evidence plans across pre- and post-launch phases.

Track record of interfacing with Commercial, Regulatory, Statistics, Scientific Communications and R&D in a matrix organisation.

Experience leading an asset or indication within medical affairs in a local affiliate (in country) role

Experience leading and developing people and teams, including indirect / matrix leadership

  Preferred Qualification ABPI (or equivalent) Code reviewer / nominated Final Medical Signatory experience.

Experience in launch excellence, scientific platform development and evidence review.

Experience of resistance, pharmacology and service-delivery / implementation science for long-acting therapies.

Demonstrated ability to influence senior internal and external stakeholders and shape policy / market environments.

Skills

Cross-Functional Leadership, Digital Fluency, Enterprise Thinking, High Impact Communication, Launch Excellence, Patient Impact  

If you require an accommodation or other assistance to apply for a job at GSK/ViiV Healthcare, please submit a request to HR via the Service Portal

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

This Position Description is to provide a framework for job understanding between employee and manager. It may not cover or contain the full listing of activities, duties or responsibilities that are required of the employee for this job. Duties, responsibilities and activities may change at any time with or without notice and at the discretion of the management of the Company. The position description is not used in the assignment or assessment of any GSK level or grade used in the Job Evaluation Process.

Compensation Grade:

4

Job Posting End Date:

23-10-2026

Eligible for Employee Referral Bonus:

Yes